Intravenous Thrombolysis for Acute Ischemic Stroke

溶栓 特奈特普酶 医学 冲程(发动机) 抗血栓 组织纤溶酶原激活剂 重症监护医学 纤溶剂 内科学 心脏病学 心肌梗塞 机械工程 工程类
作者
James C. Grotta
出处
期刊:Continuum [Lippincott Williams & Wilkins]
卷期号:29 (2): 425-442 被引量:31
标识
DOI:10.1212/con.0000000000001207
摘要

OBJECTIVE: This article reviews the history of IV thrombolysis, its current indications and implementation, the duality of the "time is brain" versus "tissue clock" approaches, the impact of endovascular thrombectomy on IV thrombolysis, the emergence of tenecteplase, and future research directions. LATEST DEVELOPMENTS: The growing use of factor Xa inhibitors has increasingly caused patients with stroke to be excluded from treatment with IV thrombolysis. Important geographic, socioeconomic, sex, race, and ethnic disparities have been identified in the implementation of IV thrombolysis and need to be overcome. IV thrombolysis substantially improves outcomes when provided within the first golden hour after stroke onset in patients treated in mobile stroke units, supporting the "time is brain" concept and encouraging the possible value of more widespread implementation of the mobile stroke unit approach. At the same time, other studies have shown that IV thrombolysis can be successful in patients whose "tissue clock" is still ticking up to 9 hours after stroke onset or in patients who awaken with their stroke, as demonstrated by favorable imaging profiles. These considerations, along with the emergence of endovascular thrombectomy, have fostered examination of our care systems, including the "drip and ship" versus direct to comprehensive or endovascular thrombectomy stroke center approaches, as well as the possibility of skipping IV thrombolysis in certain patients treated with endovascular thrombectomy. Data suggesting that tenecteplase is at least noninferior to alteplase, as well as its more convenient dosing, has led to its increased use. Ongoing studies are evaluating newer thrombolytics and adding antithrombotic therapy to IV thrombolysis. ESSENTIAL POINTS: IV thrombolysis remains the most common acute stroke treatment. Advances in acting faster to treat stroke have increased its efficacy, and advances in imaging have expanded its use. However, implementing these advances and overcoming disparities in IV thrombolysis use remain major challenges.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
以恒之心发布了新的文献求助10
刚刚
1秒前
1秒前
李健的小迷弟的应助被刘mz采纳,获得10
2秒前
研友_VZG7GZ的应助被慕容平安采纳,获得10
2秒前
shan发布了新的文献求助10
2秒前
CodeCraft的应助被xie采纳,获得10
3秒前
ivanwang0108发布了新的文献求助10
4秒前
orixero的应助被xcx采纳,获得10
4秒前
4秒前
Dddxxx完成签到,获得积分10
5秒前
今后的应助被魔幻灵煌采纳,获得10
6秒前
chirck发布了新的文献求助10
7秒前
chirck发布了新的文献求助10
7秒前
chirck发布了新的文献求助10
7秒前
7秒前
7秒前
xiaoliu完成签到,获得积分10
8秒前
以恒之心完成签到,获得积分10
9秒前
思源的应助被hh采纳,获得10
9秒前
Orange的应助被你是我的唯一采纳,获得10
10秒前
wangxinlei发布了新的文献求助10
10秒前
10秒前
zzl完成签到 ,获得积分10
12秒前
aajhajkahna的应助被未见山采纳,获得10
12秒前
12秒前
momo完成签到,获得积分10
12秒前
12秒前
Lin发布了新的文献求助10
12秒前
14秒前
14秒前
欢喜丝发布了新的文献求助10
16秒前
斯文败类的应助被LL采纳,获得10
16秒前
16秒前
gyro发布了新的文献求助10
16秒前
忘忧草完成签到 ,获得积分10
17秒前
17秒前
Joker完成签到,获得积分0
17秒前
luwa关注了科研通微信公众号
18秒前
18秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1500
John McDowells Bildungstheorie 800
Analyses de reconnaissances de dettes passées devant les échevins d'Ypres (1249-1291) 600
Handbook of Pharmaceutical Excipients. 9th ed 400
Synthesis, Application and Future Perspectives of Smart Nano-materials - Part 1 400
Breaking the World 300
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8153710
求助须知:如何正确求助?哪些是违规求助? 9550475
关于积分的说明 21698625
捐赠科研通 7742521
什么是DOI,文献DOI怎么找? 3425571
关于科研通互助平台的介绍 2550735
邀请新用户注册赠送积分活动 2469211